High-Resolution Computed Tomography Evaluation of Interstitial Lung Disease for the Pulmonologist
AffiliationUniv Arizona, Banner Univ, Med Ctr, Div Pulm & Crit Care, Dept Med
Univ Arizona, Dept Radiol, Banner Univ, Div Diagnost Radiol, Med Ctr
KeywordsInterstitial lung disease
High-resolution computed tomography
Usual interstitial pneumonia
Nonspecific interstitial pneumonia
Chronic hypersensitivity pneumonia
Smoking-related interstitial lung disease
MetadataShow full item record
CitationNyquist, A., Mushtaq, R., Gill, F., & Yaddanapudi, K. (2020). High-Resolution Computed Tomography Evaluation of Interstitial Lung Disease for the Pulmonologist. Current Pulmonology Reports, 1-12.
JournalCURRENT PULMONOLOGY REPORTS
Rights© Springer Science+Business Media, LLC, part of Springer Nature 2020
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractPurpose of Review Interstitial lung disease encompasses variety of entities that have diverse clinical manifestations, prognosis, and treatment options. It is imperative to identify the specific disease early as delays in diagnosis can lead to irreversible damage. Studies demonstrate that treatment with certain medications and avoidance of exposures that potentiate injury can reduce disease progression. Recent Findings The use of high-resolution computed tomography has become essential for the evaluation of interstitial lung disease. Being able to accurately identify the characteristic patterns of abnormalities can lead to expedited diagnosis and has obviated the need of other diagnostic studies such as lung biopsy. High-resolution computed tomography imaging of the chest has changed the approach to the diagnosis and treatment of interstitial lung diseases. Given the numerous entities that compose this group and options for individualized treatment plans, it is imperative for pulmonologists to recognize the defining imaging characteristics.
Note12 month embargo; published 20 October 2020
VersionFinal accepted manuscript
Showing items related by title, author, creator and subject.
Partitioning of organic chlorine between bulk water and benthal interstitial water through a Kraft mill aerated lagoonNeill, Rita Helen,1958-; Amy, Gary L.; Bryant, C. Woody (The University of Arizona., 1987)This report discusses the measured distribution of total and low molecular weight organic halides through a Kraft mill aerated lagoon. Both benthal interstitial water and corresponding overlying water patterns were measured. Benthal solids were analyzed for extractable organic halide and for total halide concentration. Octanol/water partition coefficients were calculated for lagoon influent and inplant acid and caustic sewers. Ether extractables of the influent and sewers were determined at high and low pH. The extent of organic halide partitioning between the overlying water and the benthal zone is indicative of the role of biosorption in the transport of organic halide compounds from the water column to the benthal zone of the lagoon. Evidence is presented for the occurrence of microbial dehalogenation within the anoxic benthal deposit.
Interstitial Lung Disease Secondary to Long-Term Nitrofurantoin UseChin, Andrew J; Rashid, Saadri; Gharibeh, Tarek R; Kibbe, Peter S; Wynbrandt, Jonathan H; Univ Arizona, Coll Med, Dept Internal Med (INT SCIENTIFIC INFORMATION, INC, 2020-04-02)Objective: Adverse events of drug therapy Background: Interstitial lung disease, also known as diffuse parenchymal lung disease, is a group of diseases that affects the interstitium of the lungs and can lead to progressive fibrosis of the lungs. The potential causes of interstitial lung disease are broad and includes infection, malignancy, autoimmune/connective tissues diseases, inhaled substances, and certain medications. One of the medications that can cause interstitial lung disease is nitrofurantoin. Case Report: A 88-year-old man with recurrent urinary tract infections was treated with long-term nitrofurantoin prophylactic therapy. He took 100 mg of nitrofurantoin on a daily basis for over 10 years as prophylactic therapy for recurrent urinary tract infections, and subsequently developed chronic respiratory failure requiring supplemental oxygen. Chest radiography and high-resolution computed tomography imaging were performed and revealed pulmonary fibrosis consistent with interstitial lung disease. Conclusions: Although nitrofurantoin is one of the most commonly used antibiotics in the treatment of urinary tract infections and is often considered a relatively safe medication, long-term use can lead to the development of interstitial lung disease.